Log in
Enquire now
‌

US Patent 10150808 Modified antibody constant regions

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Date Filed
September 24, 2010
Date of Patent
December 11, 2018
Patent Application Number
13497269
Patent Citations Received
‌
US Patent 12122840 Method of modifying isoelectric point of antibody via amino acid substitution in CDR
0
‌
US Patent 11780908 Anti-dengue virus antibodies, polypeptides containing variant FC regions, and methods of use
‌
US Patent 11891432 Anti-dengue virus antibodies having cross-reactivity to Zika virus and methods of use
0
‌
US Patent 12116414 Method of modifying isoelectric point of antibody via amino acid substitution in CDR
0
‌
US Patent 10435458 Antibody constant region variants with reduced Fcgammar binding
‌
US Patent 10604561 Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and methods of use
‌
US Patent 10844113 Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and methods of use
‌
US Patent 10934344 Methods of modifying antibodies for purification of bispecific antibodies
‌
US Patent 11046784 Methods for controlling blood pharmacokinetics of antibodies
‌
US Patent 11248053 Method of modifying isoelectric point of antibody via amino acid substitution in CDR
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10150808
Patent Primary Examiner
‌
Michael Allen

Find more entities like US Patent 10150808 Modified antibody constant regions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.